Start with its own history
At 8.07×, ABBV.TO is 87.2% below its 4-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
TSX · ABBV.TODrug Manufacturers - GeneralUpdated Oct 25, 2026
AbbVie Inc. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
8.07×
87.2% belowthe 4-observation annual average
Share price39.6
÷Earnings per share4.9055
Price and EPS in quote currency. Calculation details
Investors are paying 8.07 for every 1 of reported earnings per share.
P/E over time
2022 – 2025
Annual P/ESelected-period average 62.88×
3-year average75.74×3 positive annual observations
5-year average62.88×4 positive annual observations
10-year average62.88×4 positive annual observations
Peer median · TTM27.08×7 peers with positive P/E
Historical P/E ratios
Annual period-end data · 4 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 96.41× | +30.2% |
| Dec 31, 2024 | 74.04× | +30.4% |
| Dec 31, 2023 | 56.77× | +133.6% |
| Dec 31, 2022 | 24.30× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How ABBV.TO compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 ABBV.TO This stockAbbVie Inc. | 8.07× |
 LLY.TOEli Lilly and Company | 42.60× |
 GILD.TOGilead Sciences, Inc. | N/M |
 ROG.TORoche Holding AG | 25.45× |
 MRK.TOMerck & Co., Inc. | 115.29× |
 PFE.TOPfizer Inc. | 39.68× |
 NVS.TONovartis AG | 23.57× |
 AMGN.TOAmgen Inc. | 27.08× |
 SNY.TOSanofi | 22.67× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does ABBV.TO’s P/E tell you?
Compare like with like
The median of the 7 positive peer ratios above is 27.08×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take ABBV.TO into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("ABBV.TO", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 39.6 ÷ EPS 4.9055 = 8.07×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Oct 25, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
ABBV.TO P/E ratio: common questions
The essentials behind the numbers.
AbbVie Inc.'s current P/E is 8.07× based on the quote data last updated Oct 25, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.